Bringing Higher Resolution And Faster Analysis To Human Microbiome Profiling

The microbiome's impact on health and disease is a hot topic among researchers, clinicians, and consumers alike. Countless exploratory studies have delved into the human microbiome's composition and its connection to various bodily functions. This surge of interest has also fueled a market brimming with pre- and probiotic products promising microbiome benefits.

The advent of next-generation sequencing (NGS) revolutionized microbiome research, enabling scientists to analyze complex microbial communities from diverse biological samples. However, despite a wealth of NGS-driven studies, concrete, actionable insights remain elusive. Moreover, NGS methods are time-consuming, costly, and complex, hindering their adoption in clinical research.

Dr. Anne-Grethe Reichelt, International Sales and BD Manager at Bio-Me, recognizes these challenges as major roadblocks to progress. To address these issues, Bio-Me and Thermo Fisher Scientific collaborated to develop Precision Microbiome Profiling (PMP™), a qPCR-based platform offering rapid, precise, and detailed microbiome analysis.

To delve deeper into PMP's potential and the future of microbiome research, access this Q&A with Dr. Reichelt about the current landscape, the solutions Bio-Me and Thermo Fisher Scientific provide, and the exciting possibilities ahead.